Found: 3
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2015
Ashrafian L.A., Sukhikh G.T., Kiselev V.I., Apolikhina I.A., Paltsev M.A., Drukh V.M., Kuznetsov I.N., Muyzhnek E.L.
The aim of the study. The clinical study of the efficacy and safety of the novel pharmaceutical composition Cervicon-DIM on the base of diindolylmethane (DIM) in vaginal suppository form in the course of the conservative treatment of cervical intraepithelial n…
Research article2013
Druh V.M., Paltcev M.A., Kiselev V.I., Kuznetsov I.N., Ashrafyan L.A., Muyjnek E.I., Pchelintseva O.I.
Preclinical experimental study of toxic and allergenic properties of new pharmaceutical composition of diindolylmethane was carried on in various doses. It was established that tested drug refers to toxicity class V (almost non-toxic pharmaceutical substance) …
Research article2012
Kiselev V.I., Alakhov V.Yu., Semov A.B., Iourtchenko L.V., Liu Lin Fang, Li Shengmin, Xu Yan, Su Xiaoxue, Muyzhnek E.L., Paltsev M.A.
There is a growing body of evidence confirming the validity of the concept of cancer stem cells (CSCs). It is becoming increasingly obvious that CSCs, possessing higher tumorigenicity, metastasis-initiating activity and chemoresistance, are a source of tumor g…